Web Analytics

3 Latest Announced Rounds

  • $34,000,000
    Seed

    1 Investors

    Technology, Information and Internet
    Jul 4th, 2025
  • $5,500,000
    Seed

    1 Investors

    Software Development
    Jul 4th, 2025
  • $28,500,000
    Series A

    2 Investors

    Venture Capital and Private Equity Principals
    Jul 4th, 2025
$840.57M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

HEPHAISTOS-Pharma

start up
France - Orsay, Île-de-France
  • 17/05/2024
  • Seed
  • $11,189,199

HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.


Related People

Frederic CAROFFFounder

Frederic CAROFF France - Boulogne-Billancourt, Île-de-France

Biotechnology entrepreneur for 10 years, I am currently the CEO of HEPHAISTOS-Pharma, a biotech company developing new immunotherapies in oncology in order to revolutionize the effectiveness of cancer treatments.

Our ONCO-Boost technology allows us to stimulate patients' immunity to treat cold tumors such as Osteosarcoma, an orphan disease, but also to increase the effectiveness of therapeutic antibodies in combination.